Das Klinikum

PD Dr. Madhumita Chatterjee

PD Dr. Madhumita Chatterjee

Akademische Mitarbeiterin-Wissenschaftlerin

Academic Staff and Scientist (Akademische Mitarbeiterin-Wissenschaftlerin),
Institute for Clinical and Experimental Transfusion Medicine

Kontakt

Telefonnummer: Novel Therapeutics In Immunothrombosis: 07071 29-81134

E-Mail-Adresse: madhumita.chatterjee@med.uni-tuebingen.de

Klinik / Institut / Zentrum

  • Thrombosis and Haemostasis
  • Cardiovascular Sciences
  • 1.1.25-presentGroup leader Institute for Clinical and Experimental Transfusion Medicine
  • 1.7.22-presentPrincipal Investigator DFG-RTG/GRK2816, Dept. of Pharmacology, Experimental Therapy and Toxicology
  • 2012-June 2022Principal Investigator DFG-TR240:A08, DSHF F/22/17 (Deutsche Stiftung für Herzforschung), Memeber of TUEPIC adn associated researcher DFG-KFO274-TP1, Dept. of Cardiology and Angiology
  • 2009-2011Postdoctoral Diploma, Karolinska Institute, Stockholm, Sweden
  • 2003-2008PhD, Central Drug Research Institute, India
  • Chatterjee M. GPIIb/IIIa commanded platelet patrol. Blood in press 2022. Editorial Blood . 2022 Jul 14;140(2):81-83. doi: 10.1182/blood.2022016697.
  • Cebo M, Dittrich K, Manke MC, Rheinlaender J, von Eysmondt H, Ferreirós N, Sudman J, Witte A, Pelzl L, Borst O, Rath D, Bakchoul T, Gawaz M, Schäffer TE, Lämmerhofer M, Chatterjee M. Platelet Chemokine Receptor ACKR3/CXCR7 Favors Anti-platelet Lipids over an Atherothrombotic Lipidome and Regulates Thrombo-inflammation. Blood. 2022 Mar 17;139(11):1722-1742.
  • Rath D, Rapp V, Schwartz J, Winter S, Emschermann F, Arnold D, Rheinlaender J, Büttcher M, Strebl M, Braun M, Altgelt K, Petersen Uribe A, Schories C, Canjuga D, Schaeffeler E, Borst O, Schäffer T, Langer H, Stehle T, Schwab M, Geisler T, Gawaz M, Chatterjee M. Homophilic interaction between Transmembrane-JAM-A and soluble JAM-A regulates thrombo-inflammation. JACC- Basic to Translational Science. 2022. 2022;7: 445-461.
  • Chatterjee M, Rath D, Schlotterbeck J, Rheinlaender J, Walker-Allgaier B, Alnaggar N, Zdanyte M, Müller I, Borst O, Geisler T, Schäffer TE, Lämmerhofer M, Gawaz M. Regulation of oxidized platelet lipidome: implications for coronary artery disease. Eur. Heart J. 2017; 38:1993-2005.
  • Chatterjee M. Atypical roles of the Chemokine Receptor ACKR3/CXCR7 in platelet Pathophysiology.Cells. 2022 Jan 9;11(2):213. doi: 10.3390/cells11020213.
  • Chatterjee M. Platelet Lipidome: dismantling the ‘Trojan horse’ in the bloodstream. J. Thromb. Hemost. 2020; 18:543-557.
  • Chatterjee M, Borst O, Walker B, Fotinos A, Vogel S, Seizer P, Mack A, Alampour-Rajabi S, Rath D, Geisler T, Lang F, Langer HF, Bernhagen J, Gawaz M. Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling. Circ. Res. 2014; 115: 939-49.
  • Chatterjee M, Seizer P, Borst O, Schönberger T, Mack A, Geisler T, Langer HF, May AE, Vogel S, Lang F, Gawaz M. SDF-1α induces differential trafficking of CXCR4-CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival. FASEB J. 2014; 28:2864-78.
  • Chatterjee M, von Ungern-Sternberg S, Seizer P, Schlegel F, Büttcher M, Sindhu NA, Müller S, Mack A, Gawaz M. Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7. Cell Death Dis. 2015; 19: 6: e1989.
  • Publikationen